期刊文献+

骨髓增生异常综合征-难治性中性粒细胞减少1例及文献复习 被引量:2

Myelodysplastic syndrome with refractory neutropenia-a case report and literature review
暂未订购
导出
摘要 目的:总结1例骨髓增生异常综合征-难治性中性粒细胞减少(MDS-RN)患者的诊疗体会。方法:对1例MDS-RN患者进行形态学、细胞化学、染色体核型分析,并用流式细胞术检测免疫表型,同时进行融合基因多重PCR扩增。结果:患者血常规示白细胞0.86×109/L,中性粒细胞绝对值0.25×109/L,红细胞3.86×1012/L,血红蛋白120g/L,血小板196×109/L,骨穿示粒系病态造血,巨核细胞系亦可见病态造血改变,前者比例超过10%,而后者比例未达10%;骨髓活检发现ALIP现象;染色体检查示:47,XX,+8[6]/46,XX[7],FISH:cen8三体为24%;中性粒细胞碱性磷酸酶测定为0,给予粒细胞集落刺激因子(G-CSF)后患者中性粒细胞轻度升高。结论:RN的细胞遗传学、预后因素及临床治疗方案还有待进一步资料来完善。我们观察的这1例患者对刺激造血和免疫抑制剂疗效都不佳,其临床行为还在观察中。 Objective:To summary the diagnosis and treatment of a case of myelodysplastic syndrome with refractory neutropenia(MDS-RN).Method:The patient with MDS-RN was examined on morphology,cell chemistry and chromosome karyotype.The immunophenotype was detected by flow cytometry,and the fusion genes were amplified by multiple PCR.Result:Peripheral blood test showed WBC 0.86×109/L,NE 0.25×109/L,RBC 3.86×1012/L,Hb 120g/L,PLT 196×109/L.Bone marrow aspiration result demonstrated granulocytic and megakaryocyte dysplasia.The former proportion exceeded 10%,but the latter was less than 10%.Bone marrow biopsy data exhibited the phenomenon of ALIP.Chromosome test result showed: 47,XX,+8[6]/46,XX[7].FISH result found that the proportion of cen8 trisomy was 24%.The result of neutrophil alkaline phosphatase detection was 0.Even after the treatment of granulocyte colony stimulating factor(G-CSF),neutrophil count only increased slightly.Conclusion:More informations are still needed to clarify the cytogenetics,prognosis and clinical therapeutic regimen of RN.In this case, hematopoietic stimulating and immunosuppressive agents were not effective.The clinical behavior of this patient is still on observing.
出处 《临床血液学杂志》 CAS 2011年第2期139-141,共3页 Journal of Clinical Hematology
基金 国家科技支撑计划(No:2008BAI61B02) 江苏省青年科技创新人才基金(No:BK2004424) 江苏省高校自然科学研究项目(No:09KJB320015) 苏州市社会发展及医药项目(No:SS08024)
关键词 骨髓增生异常综合征 难治性血细胞减少伴一系病态造血 难治性中性粒细胞减少 myelodysplastic syndromes refractory cytopenias with unilineage dysplasia refractory neutropenia
  • 相关文献

参考文献8

  • 1SWERDLOW S H,CAMPO E,HARRIS N L,et al.WHO Classification of Tumours of Haematopoieticand Lymphoid Tissues[M].Lyon,France:IARC,2008:88-98.
  • 2PALLISGAARD N,HOKLAND P,RIISHJ D C,et al.Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia[J].Blood,1998,92:574-588.
  • 3VARDIMAN J W,THIELE J,ARBER D A,et al.The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia:rationale and important changes[J].Blood,2009,114:937-951.
  • 4何广胜,邵宗鸿.骨髓增生异常综合征维也纳诊断标准解读(一)[J].中国实用内科杂志,2008,28(10):884-887. 被引量:13
  • 5ORAZI A,ALBITAR M,HEEREMA N A,et al.Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens[J].Am J Clin Pathol,1997,107:268-274.
  • 6VARDIMAN J W.Hematopathological concepts and controversies in the diagnosis and classification of myelodysplastic syndromes[J].Hematol Am Soc Hematol Educ Program,2006,2006:199-204.
  • 7BRUNNING R,MCKENNA R.Tumors of the bone marrow.Atlas of tumor pathology[M].Washington,DC:Armed Forces Institute of Pathology,1994:143-194.
  • 8曹燕然,邵宗鸿,施均,王化泉,刘鸿,付蓉,赵明峰,何广胜,白洁,涂梅峰,邢莉民,崔振珠,孙娟,贾海蓉,杨天楹.骨髓增生异常综合征多指标综合诊断的前瞻性研究[J].中国实用内科杂志,2006,26(8):1145-1147. 被引量:13

二级参考文献12

  • 1施均,邵宗鸿,刘鸿,陈桂彬,张益枝,白洁,何广胜,付蓉,赵明峰,曹燕然,吴玉红,井丽萍,郝玉书,杨天楹,杨崇礼.联合化疗治疗高危组骨髓增生异常综合征及其转化的急性髓系细胞白血病疗效分析[J].中国实用内科杂志,2004,24(9):531-532. 被引量:9
  • 2施均,邵宗鸿,刘鸿,白洁,曹燕然,何广胜,凃梅峰,王秀丽,郝玉书,杨天楹,杨崇礼.Transformation of myelodysplastic syndromes into acute myeloid leukemias[J].Chinese Medical Journal,2004(7):963-967. 被引量:9
  • 3Vanlet P, Horny HP, Bennet JM, et al. Definitions and standards in the diagnosis and treatment of myelodysplatic snydromes:Consensus statements and report from a working conference [ J ]. Leuk Res,2007 ,31:727 - 736.
  • 4Komrokji RS, Bennett JM. Evolving classifications of the myelodysplastic syndromes[J]. Curr Opin,2007,14:98 - 105.
  • 5Bennett JM, Catovsky D, Daniel MT, et at. Proposals for the classification of the myelodysplastic syndromes [ J ]. Br J Haematol, 1982,51 : 189 - 199.
  • 6Germing U,Strupp C, Kuendgen A, et al. Refractory anaemia with excess of blasts ( RAEB ) : analysis of reclassification according to the WHO proposals [ J]. Br J Haematol,2006,132 : 162 - 167.
  • 7Strupp C, Gattennann N, Giagounidis A, et al. Refractory anemia with excess of blasts in transformation : analysis of reclassification according to the WHO proposals [ J ]. Leuk Res, 2003,27 : 397 - 404.
  • 8Rosati S, Mick R, Xu F, et al. Refractory cytopenia with multilineage dysplasia:further characterization of an ' unclassifiable' myelodysplastic syndrome [ J ]. Leukamia, 1996,10:20 - 26.
  • 9Cermak J, Michalova K, Brezinova J, et al. A prognostic impact of the separation of refractory cytopenia with multilineage dysplasia and 5q^- syndrome from refractory anemia in primary myelodysplastic syndrome[J]. Leu Res,2003 ,27 :221 - 229.
  • 10Brunning RD, Bennett JM, Flandrin G, et al. Myelodysplastic syndromes [ M ]//Jaffe ES, Harris NL, Stein H, et al. World Health Organization classification of tumours. Pathology & genetics. Tumours of haematopoietic and lymphoid tissues, Lyon: IARC Press,2001,62 - 73.

共引文献24

同被引文献7

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部